Insider Transactions in Q1 2024 at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
300,000
+2.48%
|
$12,900,000
$43.76 P/Share
|
|
Mar 07
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
250,000
+3.64%
|
$9,750,000
$39.54 P/Share
|
|
Feb 27
2024
|
Dominic Smethurst Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Feb 12
2024
|
Sean F. Moran Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,176
+46.18%
|
-
|
|
Feb 12
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,947
+46.7%
|
-
|
|
Feb 02
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
750,000
+33.71%
|
$14,250,000
$19.0 P/Share
|
|
Jan 26
2024
|
Alan F Holmer |
BUY
Exercise of conversion of derivative security
|
Direct |
629
+31.32%
|
$2,516
$4.97 P/Share
|
|
Jan 26
2024
|
Yuval Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,179
+50.0%
|
$28,716
$4.97 P/Share
|
|
Jan 26
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
282,632
+3.28%
|
$9,044,224
$32.17 P/Share
|